Pneumonia

New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.

ICYMI: A quick look at 7 key drugs FDA-approved in the second quarter for conditions commonly seen in primary care.

The novel vaccination is recommended as an option for adults aged 65 years and older who have not received a pneumococcal conjugate vaccine.

Capvaxive is the only pneumococcal vaccine formulated specifically to protect adults 50 years and older from IPD and elicited robust immune responses in both vaccine-naïve and vaccine-experienced adults.

More than 1 in 10 older adults were misdiagnosed with community-acquired pneumonia and nearly all were treated with a full course of antibiotics, a new study found.

The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.

If approved the 21-valent shot would be the first pneumococcal conjugate vaccine indicated specifically for adults.

Data presented at CHEST 2023 shows treatment with hydrocortisone is associated with a decrease in morality among patients with community-acquired pneumonia.

Statistically significant positive immune responses were observed in both vaccine-naive adults and those previously vaccinated, including for the vaccine's 8 unique serotypes.

New CDC recommendations for pneumococcal vaccination for persons aged 19 to 64 years could require some extra thought. This 4-question quiz tests your knowledge.

Get a quick topline look at specific revisions and additions included in the ACIP's recommendations for routine immunization of those aged ≥19 years in the US.

Respiratory syncytial virus is an age-old winter foe that could affect many of your patients this year. Take a minute and scan these facts for a refresher.

In persons with COPD, seasonal influenza and PPSV23 vaccines, separately or together, reduced the risk for COPD- and pneumonia-related hospitalizations.

The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.

How much do you know about diphtheria and the vaccine? Answer these 2 questions to find out.

SAMPLE: A 7-year-old child newly immigrated to the US has not received any previous pneumococcal vaccines. What does the CDC recommend for this child?

How much do you know about the latest adult pneumococcal vaccine recommendations from the ACIP? Try your hand at these 4 questions to find out.

Low rates of routine adult vaccination, reduced further during the 2020-21 pandemic months, threaten a surge in these conditions as the US reopens, says the National Adult and Influenza Immunization Summit.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.

Rates of routine ACIP-recommended vaccination have been persistently and significantly lower among racial and ethnic minorities over the past decade, according to new research.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

The vaccine is indicated for prevention of invasive disease and pneumonia caused by 20 Streptococcus pneumoniae serotypes.

Longer antibiotic treatment courses can often be safely and effectively shortened, according to the ACP guidance; 4 common conditions serve as examples.

Routine adult vaccination rates have yet to reach pre-pandemic levels, according to a report in MMWR this week. Which vaccines are most affected and which groups are lagging?

Review changes to the CDC Advisory Committee on Immunization Practices' 2021 recommended vaccination schedule for adults with this short slide-show review.